Thursday, 21 Sep 2017

You are here

The RheumNow Week in Review – 2 June 2017

Dr. Jack Cush reviews highlights from the past week on RheumNow.com. 

  1. 108 Early RA pts (<6 mos) 41% use CAM/nutraceutical.CAM & higher DAS28 had 7 mo DMARD delay; Higher HAQ levels associated with shorter delay in DMARD use. https://t.co/XQYwDyReWi
  2. 33 pts with Axial Spondyloarthritis Rx with NSAIDs decreased their MRI sacroiliitis and BM edema with longterm NSAIDs only https://t.co/LWMuGSDiFc
  3. Scleroderma Lung Study I/II CTX and MMF were associated with significant reductions in skin thickness compared to PBO @2yrs https://t.co/5LfsbTTGvC
  4. Rare MTX-induced skin necrosis w/ skin erosions, oral ulcers, cytopenia, 17% mortality. @Ris =age>60, CRI, no folate https://t.co/kaQ1oWIhGx
  5. VINDICATE mnemonic for AVN causes: Vascular, Infection, Drugs, Inflamm, Congenital, Autoimmune, Trauma, Endocrine https://t.co/d0oGGJp2Hq
  6. RA pregnant women shown to increase type 1 interferon gene expression from pre-preg to 3rd trimester https://t.co/Nar1onFQSS
  7. 23% of adult rheumatologists care for kids w/ JIA. 94% are comfortable diagnosing JIA; 76% comfortable treating JIA https://t.co/6B5XIIxntm
  8. New BSR 2017 British Society of.Rheumatology releases new guideline for Rx of gout; noting curative ULT must be offered to all pts early.
  9. Biologics Before Triple DMARD is Not Cost Effective in Rheumatoid Arthritis 
  10. High Fiber Intake May Decrease Osteoarthritis Knee Pain
  11.  Chondroitin Effective in Knee OA. Or is it?
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

CDC: 40% of U.S Adults Claim to Have Arthritis

The CDC has reported its 2013 and 2014 prevalence statistics for arthritis and other chronic medical conditions affecting U.S. adults aged ≥18 years. Data is drawn from the ongoing Behavioral Risk Factor Surveillance System (BRFSS), a state-based, telephone survey of noninstitutionalized adults. Data herein is self-reported arthritis (OA, RA, Gout, FM) and is quantified by state and metropolitan areas.

15 September 2017 The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report discusses metabolic syndrome in lupus, bisphosphonate holidays, vasculitis and vascular inflammation, vaccination, and the repeated wonders of Vitamin D.

Why Rheumatologists Should Do Better Vaccinating this Flu Season

It is well known that influenza infection is more common in patients with rheumatologic diseases. Blumentals et al. showed that patients with rheumatoid arthritis are at increased risk for influenza regardless of DMARD/biologic use and may have a 2.75-fold increased incidence of related complications (https://buff.ly/2gYNTSz).

8 September 2017: The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report includes trends in MTX use and outcomes, fibromyalgia as an inflammatory disorder, drugs that stop psoriasis pruritus, drugs that don't cause TB, cardiovascular risk, and what Rheums think of ACR/EULAR criteria.

1 September 2017: The RheumNow Week in Review

This week's report includes new data on IL-1 inhibition and protection from CV events and lung cancer, baricitinib given a reprieve, and features on infections: HBV, shingles and mortality of septic arthritis.